Chumakov Federal Scientific Center For Research And Development Of Immune-and-biological Products

This study tested a COVID-19 vaccine called CoviVac to see how well it works and how safe it is for people aged 60 and older. Researchers gave the vaccine to 200 volunteers and checked their immune response and any side effects. The main goal was to see if the vaccine triggers a …